James M. Ahlers
Executive Vice President of Corporate FinanceMr. James M. Ahlers is Chief Financial Officer of Cue Biopharma, Inc. from July 30, 2026. Mr. Ahlers was Chief Financial Officer of Vasa Therapeutics, Inc. since June 2025 until September 2025. He was Interim Chief Financial Officer at Arsenal Biosciences, Inc. since 2024. Mr. Ahlers had been the Chief Financial Officer of RenovoRx, Inc. from July 15, 2022 until February 05, 2024. He had been Chief Financial Officer at Intensity Therapeutics, Inc. since January 2022 until June 2023 and serves as its Executive Vice President of Corporate Finance since June 2023. He served as the Chief Financial Officer and Vice President of Finance & Operations at Intarcia Therapeutics, Inc. (Formerly, BioMedicines, Inc.) from February 2002 to November 2019. Mr. Ahlers served as an Executive Officer of Deloitte LLP. He served as Senior Executive Director of Finance and Operations of Intarcia Therapeutics, Inc. from March 2000 to January 2002 and served as its Secretary. From June 1999 to March 2000, Mr. Ahlers served as a consultant to U.S. From December 1994 to January 1996 and from December 1997 to June 1999, he served as Director of Finance and Administration of Titan Pharmaceuticals Inc. From January 1996 to December 1997, he served as Director of Finance and Operations of Ansan Pharmaceuticals, Inc. He has held senior finance roles with Titan Pharmaceuticals, Inc. He has provided consulting services to multiple public and private life science companies. During his career, he has managed capital raising transactions, including IPOs, which have raised in excess of two billions. In addition, he has developed and implemented international operations and global tax strategies. has served as a consulting CFO and provided finance advisory services through Danforth Advisors, LLC, a company that provides strategic and operational finance and accounting consulting services to life science companies. He assumed his role at RenovoRx as a consultant through Danforth. He also held finance roles at Medco Behavioral Care and Spectrum Foods. He started his career at Deloitte & Touche. Mr. Ahlers holds Bachelor of Science in Accounting from the University of San Francisco.
Positions
- Company NameIntensity Therapeutics, Inc.Stock CodeINTSPositionExecutive Vice President of Corporate FinanceColleagues
- LHLewis H. BenderFounder, President, CEO & Chairman of the Board
- JTJoseph TalamoChief Financial Officer
- JWJohn WesolowskiPrincipal Accounting Officer & Controller
- ELEmer LeahyIndependent Director
- MAMark A. GoldbergIndependent Director
- DJDaniel J. DonovanIndependent Director
- RLRiccardo LencioniMember of Scientific Advisory Board
